MINIMALLY INVASIVE SURGERY in Total Knee Arthroplasty (MIS GEN II)
A Prospective (Non)-Randomized Controlled Multicenter Clinical Study Of the Genesis ii Total Knee System in Minimally Invasive Total Knee Arthroplasty
Overall study design:
A prospective, randomized, multi-center clinical studies comparing the minimal invasive and the standard surgical total knee replacement technique (control) using the Genesis II total knee system. The study will collect efficacy, safety and socio-economical data over 2 years. An additional 5 years follow-up interval is optional. The objectives (short-term follow-up) of the study are to:
- Assess whether the improvement in Pain and Range of motion per Knee Society scoring system and VAS score.
- Assess whether there are any differences between the surgical techniques as regards complication rate.
- Assess whether the hospital stay and the rehabilitation time (Straight leg raise, Active/passive ROM) of the patients differs between the two techniques.
- Assess the x-ray mechanical alignment between the two techniques.
Attempts will be made to assess whether the collected peri-operative data (including incision length, blood loss, wound appearance, hospital readmissions and operative time) differs between the two surgical techniques.
The primary objectives (mid-term follow-up) of the study are to:
- Improvement in Pain and Function per Knee Society Scoring system
- Number and Extent of Radiographic Lucencies >2mm
- Revision and knee-related adverse events
- Improvement in Quality-of-life via the VAS score
5 investigational sites will participate and enroll a total of approximately 250 patients over a 12 months period. Thus, each site will enroll 50 patients.
調査の概要
研究の種類
段階
- フェーズ 4
連絡先と場所
研究場所
-
-
-
Tübingen、ドイツ、72076
- Orthopaedic Department, University Hospital
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- require primary uni- or bilateral total knee arthroplasty; available for 2 year follow up; provide informed consent; is in stable health for cardio-pulmonary conditions.
Exclusion Criteria:
- inefficient femoral or tibial bone stock; BMI >35; fixed flexion deformity >15 degrees; knee flexion of <90 degrees; varus/valgus deformity >20 degrees; active local infection; conditions that would compromise the 2 years follow up.
研究計画
研究はどのように設計されていますか?
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Minimal Invasive Surgery,
|
|
|
アクティブコンパレータ:Standard Surgical Technique
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
Pain and Range of Motion on the short term as efficacy measurements. Occurence of Adverse Events as safety measurements
時間枠:1 year
|
1 year
|
二次結果の測定
結果測定 |
時間枠 |
|---|---|
|
Occurence of Adverse Events and Radiolucent lines > 2mm Range of motion on the mid term
時間枠:2 years
|
2 years
|
協力者と研究者
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。